Text Size

Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Imperial College London.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00733759
First received: August 12, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted
  Purpose

Pulmonary arteriovenous malformations (PAVMs) are thin-walled abnormal vessels which provide direct capillary-free communications between the pulmonary and systemic circulations. Patients with PAVMs have usually have low blood oxygen levels and are at risk of other complications including strokes, brain abscesses, pregnancy-related complications and haemorrhage. We hypothesise that the complications of PAVM patients arise from their PAVMs and not the more recognised intracardiac forms of shunting. We propose to perform echocardiograms to enable assessment of the presence of other causes of capillary-free communications between the pulmonary and systemic circulations.


Condition
Pulmonary Arteriovenous Malformations

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Evaluation of Intra-Cardiac Shunts in Patients With Pulmonary Arteriovenous Malformations

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Imperial College London:

Estimated Enrollment: 45
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with pulmonary arteriovenous malformations (PAVMs)

Exclusion Criteria:

  • unable to provide informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00733759

Locations
United Kingdom
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Claire L Shovlin Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00733759     History of Changes
Other Study ID Numbers: IC/CLS10
Study First Received: August 12, 2008
Last Updated: August 12, 2008
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Congenital Abnormalities
Arteriovenous Malformations
Aneurysm
Hemangioma
Vascular Malformations
Cardiovascular Abnormalities
 Cardiovascular Diseases
Vascular Diseases
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on May 23, 2013